Effect of Turmeic in treatment of Vitiligo

Phase 3

• Conditions: vitiligo.; Vitiligo

• Registration Number: IRCT20180910040994N1
• Lead Sponsor: Islamic Azad University

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Suffering from vitiligo
Stability of lesions for at least 3 months
Less than 20 percent of skin involvement
Having symmetrical lesions

Exclusion Criteria

Generalized or progressive vitiligo
pregnancy or lactation
any history of allergy to Curcumin
patients who are resistant to other vitiligo therapies such as immunomodulators drugs , photo-therapy and etc.
any malignancy or active skin infections

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Size of lesions. Timepoint: at baseline and 1,2,3 and 4 months after using the drug. Method of measurement: imagej application.;Notice ability of lesions. Timepoint: at the end of the study. Method of measurement: Vitiligo Noticeability Scale Questionnaire.;Percentage of re-pigmentation. Timepoint: at baseline and 1,2,3 and 4 months after using the drug. Method of measurement: taking photo under wood lamp.

Secondary Outcome Measures

Name	Time	Method
Quality of life score in patients with vitiligo. Timepoint: before initiation of treatment and after finishing it. Method of measurement: Vitiligo Quality of Life Questionnaire.